KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Non-Current Liabilities (2016 - 2026)

Biogen has reported Total Non-Current Liabilities over the past 18 years, most recently at $10.0 billion for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities fell 2.51% year-over-year to $10.0 billion; the TTM value through Mar 2026 reached $10.0 billion, down 2.51%, while the annual FY2025 figure was $10.4 billion, 1.57% down from the prior year.
  • Total Non-Current Liabilities for Q1 2026 was $10.0 billion at Biogen, down from $10.4 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $13.0 billion in Q3 2023 and troughed at $9.9 billion in Q1 2023.
  • A 5-year average of $10.7 billion and a median of $10.4 billion in 2025 define the central range for Total Non-Current Liabilities.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 19.07% in 2023 and fell as far as 17.68% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $10.2 billion in 2022, then grew by 10.2% to $11.3 billion in 2023, then decreased by 5.89% to $10.6 billion in 2024, then dropped by 1.57% to $10.4 billion in 2025, then decreased by 3.74% to $10.0 billion in 2026.
  • Business Quant data shows Total Non-Current Liabilities for BIIB at $10.0 billion in Q1 2026, $10.4 billion in Q4 2025, and $10.2 billion in Q3 2025.